Edesa Biotech RPE
Qual é o RPE de Edesa Biotech?
O RPE de Edesa Biotech, Inc. é $0.00
Qual é a definição de RPE?
Receita por funcionário (RPE) é a receita dividida pelo número de funcionários de uma organização.
RPE de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com rpe semelhantes a Edesa Biotech
- Imperial Pacific International tem RPE de -HKD$428.57
- Indosolar tem RPE de -₨115.24
- Bluejay Mining Plc tem RPE de -£95.27
- Small Pharma Inc tem RPE de -CAD$89.38
- Treasury Metals tem RPE de -$82.14
- Treasury Metals tem RPE de -CAD$4.56
- Edesa Biotech tem RPE de $0.00
- medical columbus AG tem RPE de €0.45
- Nyrstar NV tem RPE de €2.96
- Talon Metals tem RPE de CAD$10.55
- Highfield Resources tem RPE de AUD$12.94
- Venus Metals tem RPE de AUD$15.15
- Buderim tem RPE de AUD$54.64